Sep 3Albatroz Therapeutics soars into Johnson & Johnson InnovationBy joining JLABS Singapore, Albatroz gains access to an ecosystem that will expedite the translation of its scientific discoveries.
Nov 9, 2023Two national appointments for Outram Bio partner Choon Peng NgChoon Peng Ng, Outram Bio partner, has been appointed to two national councils to help accelerate Singapore research towards the clinic.
Oct 17, 2023Albatroz featured as one of six leading biotech companies in SingaporeLabiotech.eu, a leading European biotech publication, lists Albatroz as an emerging leader in Singapore's biotechnology industry.
Apr 25, 2023Outram Bio leads US$3 million investment in Albatroz Therapeutics Albatroz is developing therapies to combat extracellular matrix degradation, a key contributor to cancer and arthritis.
Apr 19, 2023Outram Bio presents at SingHealth Duke-NUS AMRI Research Grand RoundsChris and Choon share practical steps towards commercializing research with 200+ biomedical community members.
Mar 19, 2023Albatroz Therapeutics wins Amgen Golden Ticket awardAmgen and NSG Biolabs announce Albatroz as winner of the first Amgen Golden Ticket in Singapore.
Dec 9, 2022Professor Hong Wanjin receives President's Science & Technology MedalProf Hong is Executive Director at IMCB and scientific advisor to Outram Bio.
Nov 22, 2022Dr. Andreas Wallnöfer receives Singapore's Public Service MedalDr Wallnöfer is Senior Advisor at EDDC and industry advisor to Outram Bio.
Oct 21, 2022Outram Bio conducts Pitching 101 session at A*STARChoon and Chris share their insights with A*STAR researchers on how to make more impactful pitches.